Souhaitez-vous accéder aux communiqués récents ?

Pharmaceutical executive brings 25+ years of international commercial leadership and rare disease experience Egham, UK – 18 June 2026 – Essential Pharma ("Essential" or "the Company"), a global...

COMMUNIQUÉ — 17.06.2026 Cyril Marie nommé membre du Directoire de Wendel Wendel annonce la nomination de Cyril Marie en qualité de membre du Directoire, Directeur général adjoint en charge de...

PRESS RELEASE — JUNE 17, 2026 Cyril Marie appointed to Wendel’s Executive Board Wendel announces the appointment of Cyril Marie as a member of the Executive Board and Executive Vice-President in...

DUBLIN and LONDON, 15 June 2026 -- Aerska, a biotechnology company using brain shuttle technology to develop RNA medicines for CNS diseases, today announces the appointment of Itziar Canamasas and Uli...

Oriva Therapeutics announces the appointment of seasoned biotech entrepreneur Dr Agnès Arbat as Chief Executive Officer.

amana welcomes Nikos Tsoskounoglou to lead quantitative market making and research, supporting the firm's next phase of growth.

Forbion announces the promotions of Jon Edwards, PhD, to General Partner, Regina Salvat, PhD, to Partner, and John McDonald, MBA, as Operating Partner.

Copenhagen, Denmark, 21 May 2026 – Antag Therapeutics (“Antag” or “the Company”), advancing personalized and flexible obesity treatment through GIP receptor antagonism, today announces the appointment...

Global experts in antibody-drug conjugate (ADC) development, oncology clinical development and early-phase trial design, appointed to support advancement of Byondis’ differentiated ADC pipeline and a...

Global experts in antibody-drug conjugate (ADC) development, oncology clinical development and early-phase trial design, appointed to support advancement of Byondis’ differentiated ADC pipeline and a...